Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Eggert Stockfleth, Ralph von Kiedrowski, R. Dominicus, et al.
Dermatology and Therapy (2016) Vol. 7, Iss. 1, pp. 81-96
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 12, pp. 1382-1394
Open Access | Times Cited: 105
European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on behalf of European Association of Dermato‐Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes)
Lidija Kandolf, Ketty Peris, Josep Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 1024-1047
Closed Access | Times Cited: 21
Topical treatments for skin cancer
Jason K. Cullen, Jacinta L. Simmons, Peter G. Parsons, et al.
Advanced Drug Delivery Reviews (2019) Vol. 153, pp. 54-64
Closed Access | Times Cited: 135
5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use
Beatriz Ewert de Oliveira, Otávio Henrique Junqueira Amorim, Lonetá Lauro Lima, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 61, pp. 102155-102155
Closed Access | Times Cited: 54
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions
Laura Del Regno, Silvia Catapano, Alessandro Di Stefani, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 3, pp. 339-352
Open Access | Times Cited: 34
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review
Domenico Arcuri, Brandon Ramchatesingh, François Lagacé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4989-4989
Open Access | Times Cited: 21
Diagnosis and therapy of actinic keratosis
Janis Thamm, Julia Welzel, Sandra Schuh
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 5, pp. 675-690
Open Access | Times Cited: 6
Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review
Nathan Jetter, Neha Chandan, Stephanie Wang, et al.
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. 4, pp. 543-557
Closed Access | Times Cited: 55
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Markus V. Heppt, Igor Dykukha, Sara Graziadio, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1654-1654
Open Access | Times Cited: 25
Patient‐reported outcomes of topical therapies in actinic keratosis: A systematic review
Ayman Grada, Steven R. Feldman, Nicola Luigi Bragazzi, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 25
Relative efficacy of 5‐fluorouracil compared with other treatments among patients with actinic keratosis: A network meta‐analysis
Yan‐Hua Wu, Nan Tang, Lanhua Cai, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 3
Open Access | Times Cited: 29
Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses
Khaled Ezzedine, C. Painchault, M. Brignone
Acta Dermato Venereologica (2020) Vol. 101, Iss. 1, pp. adv00358-adv00358
Open Access | Times Cited: 20
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
Eggert Stockfleth, Nathalie Bégeault, Alain Delarue
Dermatology and Therapy (2021) Vol. 12, Iss. 2, pp. 467-479
Open Access | Times Cited: 16
Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy
Paras Patel, Jennifer Wang, David Bitterman, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 4
Closed Access | Times Cited: 2
Diagnose und Therapie aktinischer Keratosen
Janis Raphael Thamm, Julia Welzel, Sandra Schuh
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 5, pp. 675-691
Open Access | Times Cited: 2
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp
Alise Balcere, Māra Rone Kupfere, Ingrīda Čēma, et al.
Medicina (2019) Vol. 55, Iss. 4, pp. 92-92
Open Access | Times Cited: 15
Italian expert consensus paper on the management of patients with actinic keratoses
Elvira Moscarella, Eugenia Veronica Di Brizzi, Alice Casari, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 14
Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome
Khaled Ezzedine, C. Painchault, Mélanie Brignone
Journal of Market Access & Health Policy (2020) Vol. 8, Iss. 1, pp. 1829884-1829884
Open Access | Times Cited: 12
Safety of topical interventions for the treatment of actinic keratosis
Elias A. T. Koch, Anja Wessely, Theresa Steeb, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 801-814
Closed Access | Times Cited: 11
German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
Ulrike Leiter, Markus V. Heppt, Theresa Steeb, et al.
EJC Skin Cancer (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 4
Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial
Chao‐Chun Yang, Tak‐Wah Wong, Chih‐Hung Lee, et al.
Journal of Dermatological Science (2018) Vol. 90, Iss. 3, pp. 295-302
Open Access | Times Cited: 12
Use of reflectance confocal microscopy to evaluate 5‐fluorouracil 0.5%/salicylic acid 10% in the field‐directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double‐blind, vehicle‐controlled trial
Martina Ulrich, Uwe Reinhold, M. Falqués, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 3, pp. 390-396
Closed Access | Times Cited: 9
Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)
Todd Schlesinger, Leon Kircik, J.Q. Del Rosso, et al.
SKIN The Journal of Cutaneous Medicine (2023) Vol. 7, Iss. 3, pp. 771-787
Open Access | Times Cited: 3
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv11954-adv11954
Open Access | Times Cited: 3
Skin field cancerisation: A systematic review of the literature regarding its treatment
Fernando Antônio Gomes de Andrade, Felipe Contoli Isoldi, Lydia Masako Ferreira
European Journal of Cancer Care (2020) Vol. 30, Iss. 2
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top